Table sugar could hold a cheaper, quicker key to making vital drugs

Table sugar, commonly found in households around the world, might soon become a cornerstone in the production of essential medications. Recent groundbreaking research suggests that this everyday substance, along with vinegar, could offer a novel, efficient, and inexpensive pathway to synthesize critical drugs. These findings come from a collaborative effort led by scientists at Scripps Research in the United States and the University of Bristol in the United Kingdom. Their work, published in the prestigious scientific journal *Nature*, outlines a revolutionary method for producing carbohydrate-based medicines, potentially reducing both the time and financial burden associated with their creation.

At the heart of this innovation lies the challenge of synthesizing C-glycosides, a class of sugar-based molecules crucial for developing effective pharmaceuticals. Traditionally, the formation of these molecules has been a laborious and costly process due to the difficulty of establishing a specific chemical bond within the sugar structure. This bond is essential because it enhances the stability of the drug in the human body, allowing it to function properly without being broken down prematurely. For instance, certain drugs used to manage type 2 diabetes, such as dapagliflozin, canagliflozin, and empagliflozin, depend on this precise modification to remain active in the bloodstream.

The breakthrough achieved by the research team involves a simplified method to create the necessary C-glycoside bond. Instead of relying on complex and often dangerous chemical processes, the scientists discovered that combining table sugar with a mild acid, such as vinegar, allows for a straightforward transformation. By mixing the sugar with a common reagent under mild acidic conditions, they were able to convert the sugar into a compound known as a sulfonyl hydrazide. This compound forms at the exact location needed for the C-glycoside bond, significantly streamlining the production process.

Professor Varinder Aggarwal, who co-led the study at the University of Bristol, emphasized the potential impact of this discovery. He stated that this method could revolutionize the way key medicines are manufactured, offering a more accessible and cost-effective solution. The simplicity of the technique, combined with the widespread availability of the starting materials, suggests that it could become the preferred method for producing these vital molecules in the future.

The implications extend beyond diabetes treatment. The research team demonstrated that this approach could be applied to a wide range of sugar-based compounds, including those in clinical trials and even complex natural products that previously required numerous synthetic steps. This versatility opens the door to the development of new drug classes that could address a variety of medical conditions.

Professor Phil Baran, another lead researcher from Scripps Research, highlighted the accessibility of the method. He noted that the process is so simple that it could be replicated in a home laboratory, using readily available reagents. Importantly, the team chose not to patent the method, encouraging broader application by generic drug manufacturers and others aiming to lower medication costs globally.

The traditional methods of creating C-glycosides involve multiple steps and the use of hazardous reagents to shield reactive parts of the sugar molecule. This new approach eliminates the need for such precautions, simplifying the process and reducing the risk associated with handling volatile chemicals. The use of sulfonyl hydrazide reactions enables the formation of carbon-carbon bonds through a radical mechanism, which is both efficient and scalable.

In demonstrating the practicality of their method, the researchers scaled up the process using dextrose purchased from a local pharmacy and household vinegar. The entire procedure was documented and shared online, showcasing the feasibility of applying this technique in real-world settings. This scalability is crucial for transitioning from laboratory experiments to industrial applications, ensuring that the benefits of this discovery reach a wider audience.

As the field of medicinal chemistry continues to evolve, innovations like this highlight the importance of exploring alternative pathways for drug synthesis. The ability to harness common substances for complex chemical transformations underscores the potential for significant advancements in healthcare accessibility and affordability. With further research and development, this method could pave the way for a new era in pharmaceutical manufacturing, making life-saving treatments more available to those in need.